• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Gore Innovation Center, Kenzen Team Up to Develop Dermal Biometrics Patch

by HITC Staff 01/31/2018 Leave a Comment

Gore Innovation Center, Kenzen Team Up to Develop Dermal Biometrics Patch

The Gore Innovation Center in Silicon Valley, today announced a joint development agreement and cash investment in digital health startup, Kenzen. W. L. Gore & Associates (Gore) engineers and scientists will work hand in hand with Kenzen, an innovator in precision health monitoring and insights, to develop a comprehensive wearable health monitoring system that employs biosensor data and predictive modeling to anticipate and prevent avoidable injuries and health conditions.

By integrating Gore’s advanced materials, Kenzen will enhance the comfort of these on-skin applications. The Kenzen Patch is comprised of a variety of printed sensors that continuously monitor numerous health parameters and measure a variety of attributes, including sweat, heart rate and body temperature.

The system promotes good health by using sweat biomarker analysis in its sensing platform, along with custom algorithms via a companion mobile app that provide contextual insights about an individual’s body when they are at work, even in extreme conditions. The device’s thin, breathable layers capture and deliver ongoing, real-time, clinical-grade biometric data.

Gore founded its Innovation Center in Santa Clara, so startups, researchers, corporations and customers can collaborate with Gore innovators on difficult, advanced materials challenges that are out of scope for Gore’s current commercial business. The Gore Innovation Center offers prototyping facilities, access to its deep material science expertise, and a co-working space for partners to co-develop unique solutions to difficult challenges across a wide range of industries.

 

“Discomfort, skin irritation and signal quality are among the biggest challenges for skin-based patch sensors and health monitoring devices today. For sweat analysis, the ability to continuously transport volumes of sweat to and away from our sensors is critical. The investment and joint development effort with Gore will help push past these issues by enabling us to deliver highly-breathable, flexible materials while improving sensor performance and accuracy using microfluidics,” said Kenzen CEO and Co-founder Dr. Sonia Sousa in a statement. “We presented a complex set of material requirements for sensor selectivity and sensitivity, and it became abundantly clear that Gore’s deep expertise in medical devices and high-performance fabrics would prove strategic in making Kenzen’s products more comfortable, reliable and easier to wear.”

Tagged With: Biomarker Discovery, Biomarkers, Biometric Data

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |